Top Markets
Coin of the day
Advanced Proteome Therapeutics Corporation Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Rang in aandelen #40426
Advanced Proteome Therapeutics Corporation, operating through its subsidiary... Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Aandeelprijs
$0.0002
Laatst gesynchroniseerd: 2025-05-15
Marktkapitalisatie
$149.63K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
CA
Handel Advanced Proteome Therapeutics Corporation (APTCF)

Categorie

Dividendrendementgeschiedenis voor Advanced Proteome Therapeutics Corporation (APTCF)
Het dividendrendement (TTM) van Advanced Proteome Therapeutics Corporation (aandelsymbool: APTCF) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Advanced Proteome Therapeutics Corporation (APTCF) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten